Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies

PURPOSE: To evaluate the time course of biodegradation of an intracameral, biodegradable, sustained-release bimatoprost implant that lowers intraocular pressure without the need for daily eye drops. METHODS: In 2 identically designed, randomized, phase 3 clinical trials, adults with open-angle glauc...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinreb, Robert N., Bacharach, Jason, Brubaker, Jacob W., Medeiros, Felipe A., Bejanian, Marina, Bernstein, Paula, Robinson, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885540/
https://www.ncbi.nlm.nih.gov/pubmed/36378864
http://dx.doi.org/10.1089/jop.2022.0137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885540/
https://www.ncbi.nlm.nih.gov/pubmed/36378864
http://dx.doi.org/10.1089/jop.2022.0137

Ejemplares similares